A. A. Ustyugov

1.2k total citations
67 papers, 940 citations indexed

About

A. A. Ustyugov is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, A. A. Ustyugov has authored 67 papers receiving a total of 940 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 30 papers in Neurology and 18 papers in Cellular and Molecular Neuroscience. Recurrent topics in A. A. Ustyugov's work include Amyotrophic Lateral Sclerosis Research (19 papers), Parkinson's Disease Mechanisms and Treatments (16 papers) and Alzheimer's disease research and treatments (14 papers). A. A. Ustyugov is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (19 papers), Parkinson's Disease Mechanisms and Treatments (16 papers) and Alzheimer's disease research and treatments (14 papers). A. A. Ustyugov collaborates with scholars based in Russia, United Kingdom and United States. A. A. Ustyugov's co-authors include С. О. Бачурин, Elena Bovina, Vladimir L. Buchman, Natalia Ninkina, Tatyana A. Shelkovnikova, Owen M. Peters, E. F. Shevtsova, Gjumrakch Aliev, Michail S. Kukharsky and Natalie Connor‐Robson and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

A. A. Ustyugov

62 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. A. Ustyugov Russia 16 390 268 255 253 168 67 940
Sabrina Petralla Italy 16 229 0.6× 160 0.6× 283 1.1× 51 0.2× 142 0.8× 29 636
Dong Jin Kim South Korea 18 517 1.3× 350 1.3× 186 0.7× 109 0.4× 313 1.9× 33 1.1k
Merav Yogev‐Falach Israel 10 197 0.5× 235 0.9× 321 1.3× 198 0.8× 101 0.6× 10 698
Sandrine Desrayaud Switzerland 19 485 1.2× 136 0.5× 190 0.7× 87 0.3× 157 0.9× 38 1.1k
Stefan von Berg Sweden 16 666 1.7× 402 1.5× 257 1.0× 43 0.2× 218 1.3× 21 1.3k
Michele Perni United Kingdom 17 907 2.3× 923 3.4× 122 0.5× 416 1.6× 67 0.4× 29 1.6k
Xénia Latypova France 7 642 1.6× 797 3.0× 259 1.0× 87 0.3× 44 0.3× 15 1.3k
Andrew W. Stamford United States 22 604 1.5× 171 0.6× 187 0.7× 127 0.5× 479 2.9× 51 1.5k
Katarzyna Marta Zoltowska United States 17 982 2.5× 556 2.1× 126 0.5× 272 1.1× 27 0.2× 22 1.6k
Mikko Gynther Finland 23 733 1.9× 194 0.7× 136 0.5× 50 0.2× 114 0.7× 55 1.7k

Countries citing papers authored by A. A. Ustyugov

Since Specialization
Citations

This map shows the geographic impact of A. A. Ustyugov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. A. Ustyugov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. A. Ustyugov more than expected).

Fields of papers citing papers by A. A. Ustyugov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. A. Ustyugov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. A. Ustyugov. The network helps show where A. A. Ustyugov may publish in the future.

Co-authorship network of co-authors of A. A. Ustyugov

This figure shows the co-authorship network connecting the top 25 collaborators of A. A. Ustyugov. A scholar is included among the top collaborators of A. A. Ustyugov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. A. Ustyugov. A. A. Ustyugov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Funikov, S. Yu., et al.. (2023). Dynamic Changes in the Activities and Contents of Particular Proteasome Forms in the Cerebral Cortex of C57BL/6 Mice during Aging. Molecular Biology. 57(5). 897–904. 1 indexed citations
2.
Kruglov, Andrey, Marina Bondareva, A. A. Ustyugov, et al.. (2023). Inactivated whole virion vaccine protects K18‐hACE2 Tg mice against the Omicron SARS‐CoV‐2 variant via cross‐reactive T cells and nonneutralizing antibody responses. European Journal of Immunology. 54(3). e2350664–e2350664. 2 indexed citations
3.
Shevtsova, E. F., V. V. Grigoriev, А. Yu. Aksinenko, et al.. (2023). New Adamantane-Containing Edaravone Conjugates as Potential Neuroprotective Agents for ALS Treatments. Molecules. 28(22). 7567–7567. 3 indexed citations
4.
Ustyugov, A. A., et al.. (2022). 3D Neuronal Cell Culture Modeling Based on Highly Porous Ultra-High Molecular Weight Polyethylene. Molecules. 27(7). 2087–2087. 3 indexed citations
5.
Kucheryanu, V. G., et al.. (2022). Synuclein Proteins in MPTP-Induced Death of Substantia Nigra Pars Compacta Dopaminergic Neurons. Biomedicines. 10(9). 2278–2278. 6 indexed citations
6.
Ustyugov, A. A., et al.. (2021). Phosphine modification of proline-glycine-proline tripeptide and study of its neuroprotective properties. Biochemical and Biophysical Research Communications. 539. 15–19. 2 indexed citations
7.
Vorobyov, Vasily, et al.. (2021). Cortical and Striatal Electroencephalograms and Apomorphine Effects in the FUS Mouse Model of Amyotrophic Lateral Sclerosis. Journal of Alzheimer s Disease. 81(4). 1429–1443. 2 indexed citations
8.
Ninkina, Natalia, et al.. (2020). Alterations in the nigrostriatal system following conditional inactivation of α-synuclein in neurons of adult and aging mice. Neurobiology of Aging. 91. 76–87. 27 indexed citations
9.
Неганова, Маргарита Е., et al.. (2020). Promising molecular targets for pharmacological therapy of neurodegenerative pathologies. Acta Naturae. 12(3). 60–80. 8 indexed citations
10.
Ustyugov, A. A., et al.. (2020). Fluorinated γ-carbolines as agents for delaying cognitive and motor dysfunctions in a transgenic model of neurodegenerative disorders. Russian Chemical Bulletin. 69(4). 781–786. 3 indexed citations
11.
Karlov, Dmitry S., Т. А. Воронина, V. V. Grigoriev, et al.. (2019). Novel Positive Allosteric Modulators of AMPA Receptors Based on 3,7-Diazabicyclo[3.3.1]nonane Scaffold. Molecular Neurobiology. 57(1). 191–199. 19 indexed citations
12.
Vorobyov, Vasily, N. I. Medvinskaya, Inna V. Nesterova, et al.. (2019). Loss of Midbrain Dopamine Neurons and Altered Apomorphine EEG Effects in the 5xFAD Mouse Model of Alzheimer’s Disease. Journal of Alzheimer s Disease. 70(1). 241–256. 25 indexed citations
13.
Махаева, Галина Ф., Sofya V. Lushchekina, Natalia P. Boltneva, et al.. (2017). 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment. Bioorganic & Medicinal Chemistry. 25(21). 5981–5994. 44 indexed citations
14.
Kukharsky, Michail S., Yu. V. Borodina, Andrei Surguchov, et al.. (2017). Detection of autoantibodies to potentially amyloidogenic protein, gamma-synuclein, in the serum of patients with amyotrophic lateral sclerosis and cerebral circulatory disorders. Doklady Biochemistry and Biophysics. 472(1). 64–67. 4 indexed citations
15.
Бачурин, С. О., Elena Bovina, & A. A. Ustyugov. (2017). Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends. Medicinal Research Reviews. 37(5). 1186–1225. 255 indexed citations
16.
Бачурин, С. О., et al.. (2016). The role of alpha-synuclein in the development of the dopaminergic neurons in the substantia nigra and ventral tegmental area. Doklady Biological Sciences. 466(1). 5–7. 5 indexed citations
17.
Robinson, Hannah K., Alexey V. Deykin, A. A. Ustyugov, et al.. (2015). Early lethality and neuronal proteinopathy in mice expressing cytoplasm-targeted FUS that lacks the RNA recognition motif. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 16(5-6). 402–409. 14 indexed citations
18.
Shelkovnikova, Tatyana A., Owen M. Peters, Alexey V. Deykin, et al.. (2013). Fused in Sarcoma (FUS) Protein Lacking Nuclear Localization Signal (NLS) and Major RNA Binding Motifs Triggers Proteinopathy and Severe Motor Phenotype in Transgenic Mice. Journal of Biological Chemistry. 288(35). 25266–25274. 91 indexed citations
19.
Ustyugov, A. A., Tatyana A. Shelkovnikova, Owen M. Peters, et al.. (2012). Dimebon Reduces the Levels of Aggregated Amyloidogenic Protein Forms in Detergent-Insoluble Fractions In Vivo. Bulletin of Experimental Biology and Medicine. 152(6). 731–733. 7 indexed citations
20.
Ustyugov, A. A., et al.. (2005). Analysis of DNA-Protein Interactions in Complexes of Transcription Factor NF-κB with DNA. Biochemistry (Moscow). 70(11). 1212–1222. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabrina Petralla Breakdown of academic impact, for papers by Dong Jin Kim Breakdown of academic impact, for papers by Merav Yogev‐Falach Breakdown of academic impact, for papers by Sandrine Desrayaud Breakdown of academic impact, for papers by Stefan von Berg Breakdown of academic impact, for papers by Michele Perni Breakdown of academic impact, for papers by Xénia Latypova Breakdown of academic impact, for papers by Andrew W. Stamford Breakdown of academic impact, for papers by Katarzyna Marta Zoltowska Breakdown of academic impact, for papers by Mikko Gynther
Rankless by CCL
2026